Jessica Carmen, Ph.D

SENIOR ADVISOR

Dr. Carmen has over 10 years of experience in the cell and gene therapy industry. Currently, she is a consultant working with companies across all biotechnology sectors, with an emphasis on cell and gene therapy, helping small and mid-sized biotech companies with licensing, business development, opportunity assessment, market analysis, and alliance management. She has a broad technical knowledge base in cell and gene therapies with deep understanding of manufacturing of these innovative medicines.  In her previous roles she was responsible for out licensing a non-viral enabling technology for cellular engineering at MaxCyte. Before that, she was responsible for establishing partnerships with developers of cell-based medicines in order to expand the cell therapy contract manufacturing business at Lonza.

Dr. Carmen has been instrumental in the establishment of the Standards Coordinating Body for Regenerative Medicines and is currently serving as Vice President of the Board of Directors. She is an active member of the Science and Technology Committee of the Alliance for Regenerative Medicine and has served on the Commercialization Committee for the International Society of Cellular Therapy. Jessica earned a Doctorate from the Johns Hopkins University School of Public Health and a Bachelor of Science from the University of Florida.